Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Contract/Agreement, Trade Show

SCORR Marketing and the Conference Forum to Collaborate on CRAACO Conference


SCORR Marketing, the leading full-service marketing and communications firm in the health science industry, and the Conference Forum, the leading presenter of strategic-level life science conferences, will collaborate on the 2020 Clinical Research as a Care Option (CRAACO) conference. The Conference Forum will include key initiatives and thought leaders from the Bridging Clinical Research & Clinical Health Care Collaborative at its CRAACO conference.

"We started the Bridging Collaborative in 2018 to bring all stakeholders together to address the gap between clinical research and health care," said Cinda Orr, CEO at SCORR. "Moving these discussions to CRAACO means the momentum of the Bridging Collaborative will continue as we persist in exploring ways to put patients at the center of research and care."

Although the Bridging Collaborative is changing, its key areas of focus will continue to be discussed through the CRAACO conference.

"While CRAACO approaches clinical research as a care option from a different viewpoint, we expect this collaboration will make our event stronger by bringing more voices to the conversation," said Valerie Bowling, executive director of the Conference Forum. "This enhances our ability to facilitate meaningful discussions that ultimately benefit patients."

CRAACO will be April 27?28, 2020, in Raleigh-Durham, N.C. SCORR will be the event's lead media sponsor, and SCORR Vice President of Communications Roger Boutin will serve on CRAACO's advisory board.

About SCORR Marketing
SCORR Marketing is the leading full-service marketing agency for the health science industry. With global capabilities, SCORR partners with companies involved in the research, development, and commercialization of biopharmaceutical and device products, as well as those delivering health care products and services. SCORR provides integrated programs to help clients achieve their goals and improve health and well-being worldwide. Learn more at scorrmarketing.com.

About the Conference Forum
The Conference Forum is a life science industry research firm that develops conferences primarily around how to get therapeutics to patients faster. The Conference Forum examines and challenges the complex ecosystem of drug development and delivery, bringing ideas together from a variety of sources to help advance clinical research with common goals that are patient-focused.


These press releases may also interest you

at 10:45
The "PCR Markets. Forecasts for qPCR, dPCR, Singleplex & Multiplex Markets and by Application, Product and Place. With Executive and Consultant Guides, Including Customized Forecasting and Analysis. 2023 to 2027" report has been added to...

at 10:31
Gulfstream Aerospace Corp., a wholly owned subsidiary of General Dynamics , today announced the all-new Gulfstream G700 has received Federal Aviation Administration (FAA) type certification, paving the way for customer deliveries of the most spacious...

at 10:30
The "Licensing Deals in Biotechnology 2019-2024" report has been added to ResearchAndMarkets.com's offering. Licensing Deals in Biotechnology provides a detailed understanding and analysis of how and why companies enter licensing deals. Fully...

at 10:30
The "Molecular Diagnostics for Cancer: Markets Forecasts by Cancer Type, Product, and Place with Executive & Consultant Guides and Customization. 2023 to 2027" report has been added to ResearchAndMarkets.com's offering. Exciting technical...

at 10:30
RIVANNA®, a developer of imaging-based medical solutions, names Craig Loomis as senior director of product management. With over 25 years of extensive experience in global product development and commercialization within the healthcare sector, Mr....

at 10:15
The Micro-electro-mechanical System (MEMS) market is projected to grow from USD 16.5 billion in 2024 and is estimated to reach USD 24.2 billion by 2029; it is expected to grow at a Compound Annual Growth Rate (CAGR) of 7.9% from 2024 to 2029...



News published on and distributed by: